United Kingdom· GB-APID-4506411000001104
Cetrotide 3mg powder and solvent for solution for injection vials
A cetrorelix product containing cetrorelix, registered in United Kingdom by Merck Serono Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Cetrorelix is registered in 15 of 19 countries.
Countries holding a registration under ATC H01CC02 (cetrorelix), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Cetrorelix · ATC H01CC02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of cetrorelix costs, country by country.
Normalised to the WHO defined daily dose (0.25 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cetrorelix · price per daily dose (0.25 mg)
USD · FX 28 Sept 2026
- ES Spain$40.95
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Cetrorelix
- Manufacturer
- Merck Serono Ltd
- Country
- United Kingdom (GB)
- ATC code
- H01CC02
- ATC class
- Cetrorelix
- Defined daily dose
- 0.25 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5018431600015
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cetrorelix in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCetrotide 3 mgMerck Europe
- FinlandCetrotideMerck Serono Europe Limited
- SpainCETRORELIX EDEST 0,25 MG POLVO PARA SOLUCION INYECTABLEIntas Third Party Sales 2005 S.L.
- CzechiaCETROTIDEMerck Europe B.V., Amsterdam
- IrelandCetrotide 0.25 mg powder and solvent for solution for injectionMerck Europe B.V.
- SwitzerlandCetrorelix Leman 0,25 mg, poudre pour solution injectableLeman SKL SA
- FranceCETROTIDE 0,25 mg, poudre et solvant pour solution injectableMERCK EUROPE (PAYS-BAS)
- NetherlandsCetrotide 0,25 mg, poeder voor oplossing voor injectieMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Ceziboe
- Czechia · Cetrorelix Sun, Ceziboe
- Germany · Ceziboe
- Spain · Ceziboe Sun
- France · Ceziboe
- Greece · Ceziboe
- Hungary · Ceziboe
- Ireland · Ceziboe
- Iceland · Cetrotide
- Italy · Ceziboe
- Liechtenstein · Cetrotide
- Netherlands · Ceziboe
- Norway · Cetrotide
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dde48b0f-b88a-45b4-ae27-00bd8328c2c3 GET /v1/drugs/dde48b0f-b88a-45b4-ae27-00bd8328c2c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4506411000001104",
"desc": "Cetrotide 3mg powder and solvent for solution for injection vials (Merck Serono Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "36135111000001105",
"source": "dmd",
"vtm_id": "775146004",
"strength": "3 mg",
"substance": "Cetrorelix",
"ingredient": "Cetrorelix acetate",
"supplier_code": "13383811000001106"
}See everything about cetrorelix.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.